About EchoNous
EchoNous is a medical technology company pioneering AI-enhanced point-of-care ultrasound (POCUS) solutions. Founded in 2016 in Redmond, Washington, the company's name translates to 'intelligent sound' — combining echo (sound) with nous (intelligence) — reflecting its mission to integrate artificial intelligence with miniaturized ultrasound technology. EchoNous develops the Kosmos platform, which delivers cart-based ultrasound performance in a portable, handheld form factor. The platform features proprietary deep learning algorithms that provide real-time guidance for image acquisition and automated clinical measurements, enabling both novice and expert users to perform high-quality ultrasound examinations at the bedside. Kosmos offers advanced capabilities previously limited to larger systems, including Pulsed Wave (PW) Doppler, Continuous Wave (CW) Doppler, Tissue Doppler Imaging (TDI), and Color Doppler. The AI suite includes automated ejection fraction calculations, FAST exam anatomical labeling, bladder volume measurements, and auto-preset optimization across cardiac, lung, and abdominal applications. The company serves multiple clinical specialties including emergency medicine, critical care, cardiology, anesthesiology, nephrology, vascular access, family medicine, and OB/GYN. EchoNous manufactures its devices in the United States and maintains HIPAA and SOC2 compliance. The platform is compatible with proprietary displays as well as select Apple iOS and Android tablets, offering flexibility for clinical workflows. With a team comprising experts from ultrasound, AI, industrial design, and software engineering, EchoNous aims to make advanced diagnostic ultrasound accessible and actionable at the point of care.
Mission & Story
Mission
Our mission is to redefine the world of POCUS by bringing premium ultrasound technology together with industry-leading AI to transform Point-of-Care ultrasound and make results more accessible for providers and patients alike.
Founding Story
The story of EchoNous begins in Redmond, Washington with its founding in 2016. The founding belief was to add the emerging field of artificial intelligence (AI) with extreme miniaturization of ultrasound to put high level diagnostic tools in the hands of clinicians to help solve everyday problems in healthcare. The team comprises boundary pushing innovators from diverse domains such as healthcare, artificial intelligence, industrial design, manufacturing, and software engineering.
Clinical Focus
Medical conditions and clinical areas addressed by EchoNous.
Who It Serves
Milestones & Awards
Recent Milestones
June 2026: Expanded Kosmos clinical capabilities with Vascular Auto Flow, advanced cardiac tools, and connectivity features. Launched Kosmos Bladder AI for automated bladder volume calculations. Introduced Kosmos EDU educational application for novice users.
Key Partnerships
Company Details
- Founded
- 2016
- Headquarters
- Redmond, WA, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.